commonly, scleral necrosis [2] . In this report, we describe a patient with a ciliochoroidal melanoma treated with I-125 plaque radiotherapy who later developed progressive scleral necrosis and a protruding episcleral mass, raising the concern for recurrent melanoma.
Introduction
Eye-preserving treatments are usually preferred for patients with medium-sized posterior uveal melanoma of a nonjuxtapapillary location, since there is no survival difference between patients treated with radiation versus enucleation [1] . However, radiation treatment may have an impact on patient morbidity due to its side effects including cataract, retinopathy, maculopathy, and less brachytherapy when it progressed to a distinctively nodular protruding lesion ( fig. 1 e) . B-scan ultrasound showed a relatively stable intraocular tumor ( fig. 1 f) , raising our concern for local tumor relapse and possible extraocular tumor extension. After explaining the potential risk of tumor recurrence versus the status of the eye, the patient agreed to have enucleation OS.
Gross examination of the enucleated globe revealed massive bleeding, resulting in a brown staining of intraocular structures, retinal detachment, neovascularization of the iris, cataract, and a regressed solid ciliochoroidal mass protruding through the sclera ( fig. 2 a, b) . Histopathology showed focal, full-thickness scleral necrosis superonasally, overlying a necrotic mass with patchy chronic, nongranulomatous inflammation, but no evident vasculitis ( fig. 2 c, f) . The extruded, nodular tissue consisted mainly of organized cholesterol clefts and exudative material with pigment granules and rare macrophages ( fig. 2 d) . The irradiated tumor was composed mainly of small pyknotic cells with foamy cytoplasm and rare morphologically intact spindle and epithelioid melanoma cells ( fig. 2 e) . The vitreous was dense and filled with proteinaceous material, and the retina was mostly atrophic and gliotic. Although a few viable appearing tumor cells were present within the sclera, no definite tumor cells were extending outside the sclera.
Discussion
Our group has previously reported a patient with ciliochoroidal melanoma treated by I-125 plaque radiotherapy that developed scleral necrosis 1 month after treatment [3] . Nevertheless, the patient reported herein developed a scleral lesion approximately 2 years after brachytherapy. While scleral necrosis has been reported after plaque radiotherapy treatment for choroidal melanoma, it is relatively rare (1%) in patients treated specifically with I-125 [2] .
The diagnosis of scleral necrosis is mainly clinical [4] , and its course can be unpredictable [2] . Thus, distinguishing extraocular tumor extension after radiation from severe progression of scleral necrosis can be challenging.
The exact pathophysiology of scleral necrosis is unknown, but several mechanisms have been proposed. Although the patient received the recommended dose of 138 radiation to the sclera, scleral necrosis has been reported to occur after radiation doses of ≥ 400 Gy [2] to the sclera and 88.3 Gy to the tumor base [4] . Other possibilities that could not be entirely excluded were surgically induced local ischemia, granulomatous inflammation from suture material at the time of plaque placement, or scleral perforation during plaque implantation or extraocular muscle disinsertion/reinsertion. Another possible etiology is secondary occult vasculitis caused by infectious or systemic inflammatory disorders. The timing Color version available online of scleral necrosis resulting from radiotherapy has also been noted to have a mean onset of 32 months after radiotherapy. Our case features an unusual presentation of scleral necrosis after plaque radiotherapy, simulating tumor recurrence with extraocular extension. The management of uveal melanoma requires a careful clinical follow-up, weighing the implications of treatment morbidity and mortality.
